ATE439359T1 - Inhibitoren der cdc25 phosphatase - Google Patents
Inhibitoren der cdc25 phosphataseInfo
- Publication number
- ATE439359T1 ATE439359T1 AT05826562T AT05826562T ATE439359T1 AT E439359 T1 ATE439359 T1 AT E439359T1 AT 05826562 T AT05826562 T AT 05826562T AT 05826562 T AT05826562 T AT 05826562T AT E439359 T1 ATE439359 T1 AT E439359T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- cdc25 phosphatase
- cdc25
- phosphatase
- dione
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0413456A FR2879598B1 (fr) | 2004-12-17 | 2004-12-17 | Inhibiteurs de phosphatases cdc25 |
PCT/FR2005/003161 WO2006067311A2 (fr) | 2004-12-17 | 2005-12-16 | Inhibiteurs de phosphatases cdc25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE439359T1 true ATE439359T1 (de) | 2009-08-15 |
Family
ID=34954106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05826562T ATE439359T1 (de) | 2004-12-17 | 2005-12-16 | Inhibitoren der cdc25 phosphatase |
Country Status (15)
Country | Link |
---|---|
US (1) | US8017637B2 (de) |
EP (1) | EP1831209B1 (de) |
JP (1) | JP2008524175A (de) |
AT (1) | ATE439359T1 (de) |
CA (1) | CA2591215A1 (de) |
CY (1) | CY1109596T1 (de) |
DE (1) | DE602005016014D1 (de) |
DK (1) | DK1831209T3 (de) |
ES (1) | ES2331199T3 (de) |
FR (1) | FR2879598B1 (de) |
PL (1) | PL1831209T3 (de) |
PT (1) | PT1831209E (de) |
RU (1) | RU2395510C2 (de) |
SI (1) | SI1831209T1 (de) |
WO (1) | WO2006067311A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2834289B1 (fr) | 2001-12-27 | 2004-03-19 | Sod Conseils Rech Applic | Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques |
FR2877667B1 (fr) | 2004-11-05 | 2007-03-23 | Sod Conseils Rech Applic | Derives de 4,7-dioxobenzothiazole-2-carboxamides, leur preparation et leurs applications therapeutiques |
FR2879598B1 (fr) | 2004-12-17 | 2007-03-30 | Sod Conseils Rech Applic | Inhibiteurs de phosphatases cdc25 |
FR2915747B1 (fr) * | 2007-05-04 | 2011-02-25 | Scras | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatase cdc25 |
FR2930552B1 (fr) * | 2008-04-24 | 2012-10-12 | Centre Nat Rech Scient | N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog |
FR2945532A1 (fr) * | 2009-05-15 | 2010-11-19 | Ipsen Pharma Sas | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatases cdc25 |
PT2968316T (pt) | 2013-03-13 | 2019-10-29 | Forma Therapeutics Inc | Derivados de 2-hidroxi-1-{4-[(4-fenilfenil)carbonil]piperazin-1-il}etano-1-ona e compostos relacionados como inibidores da sintase de ácidos gordos (fasn) para o tratamento do cancro |
US10179914B2 (en) | 2014-09-26 | 2019-01-15 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | CDC25A inhibitor for the treatment of drug resistant cancer or for the prevention of tumor relapse |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
CN113382633A (zh) | 2018-10-29 | 2021-09-10 | 福马治疗股份有限公司 | (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式 |
WO2022018667A1 (en) | 2020-07-24 | 2022-01-27 | Pfizer Inc. | Combination therapies using cdk2 and cdc25a inhibitors |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1534275A (en) | 1976-01-30 | 1978-11-29 | Shell Int Research | Herbicidal compositions containing 1,4-quinones or derivatives thereof |
US5508289A (en) * | 1994-03-14 | 1996-04-16 | The United States America As Represented By The Department Of Health And Human Services | Bis-acridone chemotherapeutic derivatives |
US5523430A (en) * | 1994-04-14 | 1996-06-04 | Bristol-Myers Squibb Company | Protein farnesyl transferase inhibitors |
US6673927B2 (en) | 1996-02-16 | 2004-01-06 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Farnesyl transferase inhibitors |
IT1293525B1 (it) * | 1997-08-01 | 1999-03-01 | Uni Degli Studi Camerino | Bis-acridincarbossiammidi aventi attivita' antitumorale |
RU2298417C2 (ru) | 1999-11-09 | 2007-05-10 | Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) | Продукт, включающий ингибитор трансдукции сигналов гетеротримерных протеинов g в комбинации с другим цитостатическим средством, для терапевтического применения при лечении рака |
JP2003518039A (ja) | 1999-12-21 | 2003-06-03 | アストラゼネカ アクチボラグ | Cd45阻害剤 |
TW200304375A (en) | 2001-12-06 | 2003-10-01 | Maxia Pharmaceuticals Inc | 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
FR2834289B1 (fr) * | 2001-12-27 | 2004-03-19 | Sod Conseils Rech Applic | Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques |
ATE368654T1 (de) * | 2001-12-27 | 2007-08-15 | Sod Conseils Rech Applic | Benzothiazol- und benzoxazol-4,7-dionderivate und ihre verwendung als cdc25-phosphatasen- inhibitoren |
FR2856688B1 (fr) | 2003-06-25 | 2008-05-30 | Sod Conseils Rech Applic | PRODUIT COMPRENANT AU MOINS UN INHIBITEUR DE PHOSPHATASE CDc25 EN ASSOCIATION AVEC AU MOINS UN AUTRE AGENT ANTI-CANCEREUX |
FR2856686A1 (fr) | 2003-06-25 | 2004-12-31 | Sod Conseils Rech Applic | Benzothiazole-4,7-diones et benzooxazole-4,7-diones substituees en position 5 ou 6 et leurs procedes de preparation |
FR2877667B1 (fr) | 2004-11-05 | 2007-03-23 | Sod Conseils Rech Applic | Derives de 4,7-dioxobenzothiazole-2-carboxamides, leur preparation et leurs applications therapeutiques |
FR2879598B1 (fr) | 2004-12-17 | 2007-03-30 | Sod Conseils Rech Applic | Inhibiteurs de phosphatases cdc25 |
-
2004
- 2004-12-17 FR FR0413456A patent/FR2879598B1/fr not_active Expired - Fee Related
-
2005
- 2005-12-16 US US11/722,075 patent/US8017637B2/en not_active Expired - Fee Related
- 2005-12-16 PL PL05826562T patent/PL1831209T3/pl unknown
- 2005-12-16 CA CA002591215A patent/CA2591215A1/fr not_active Abandoned
- 2005-12-16 DE DE602005016014T patent/DE602005016014D1/de active Active
- 2005-12-16 WO PCT/FR2005/003161 patent/WO2006067311A2/fr active Application Filing
- 2005-12-16 SI SI200530820T patent/SI1831209T1/sl unknown
- 2005-12-16 JP JP2007546121A patent/JP2008524175A/ja active Pending
- 2005-12-16 PT PT05826562T patent/PT1831209E/pt unknown
- 2005-12-16 DK DK05826562T patent/DK1831209T3/da active
- 2005-12-16 EP EP05826562A patent/EP1831209B1/de not_active Not-in-force
- 2005-12-16 RU RU2007127250/04A patent/RU2395510C2/ru not_active IP Right Cessation
- 2005-12-16 ES ES05826562T patent/ES2331199T3/es active Active
- 2005-12-16 AT AT05826562T patent/ATE439359T1/de active
-
2009
- 2009-11-11 CY CY20091101174T patent/CY1109596T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US8017637B2 (en) | 2011-09-13 |
US20090275624A1 (en) | 2009-11-05 |
RU2007127250A (ru) | 2009-01-27 |
PT1831209E (pt) | 2009-11-04 |
FR2879598A1 (fr) | 2006-06-23 |
WO2006067311A2 (fr) | 2006-06-29 |
EP1831209A2 (de) | 2007-09-12 |
PL1831209T3 (pl) | 2010-01-29 |
JP2008524175A (ja) | 2008-07-10 |
ES2331199T3 (es) | 2009-12-23 |
CY1109596T1 (el) | 2014-08-13 |
WO2006067311A3 (fr) | 2006-08-17 |
CA2591215A1 (fr) | 2006-06-29 |
DE602005016014D1 (de) | 2009-09-24 |
DK1831209T3 (da) | 2009-11-30 |
FR2879598B1 (fr) | 2007-03-30 |
SI1831209T1 (sl) | 2010-01-29 |
RU2395510C2 (ru) | 2010-07-27 |
EP1831209B1 (de) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE439359T1 (de) | Inhibitoren der cdc25 phosphatase | |
EA200701467A1 (ru) | Пирролидиновые ингибиторы иап (ингибиторов апоптоза) | |
NO20081636L (no) | FAP - inhibitorer | |
BR0313330A (pt) | Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4 | |
ATE471324T1 (de) | Triazolophthalazine | |
DK1761520T3 (da) | Kinaseinhibitorer | |
BRPI0606379A2 (pt) | triazolftalazinas | |
DK1853602T3 (da) | Kemiske forbindelser | |
DK1853588T3 (da) | Kemiske forbindelser | |
MD20150085A2 (ro) | Inhibitori ai histon-demetilazelor | |
ATE486870T1 (de) | Jnk inhibitoren | |
MY146037A (en) | Isoquinoline derivatives as inhibitors of rho-kinase | |
DK1846424T3 (da) | Proteasom-inhibitorer og fremgangsmåder til anvendelse deraf | |
UA85505C2 (en) | Kinase inhibitors | |
MX2021003843A (es) | Inhibidores de la interaccion yap/taz-tead y su uso en el tratamiento del cancer. | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
MX2010007543A (es) | Inhibidores de iap. | |
DK1814879T3 (da) | Derivater af 4,7-dioxobenzothiazol-2-caboxamider, fremgangsmåde til fremstilling deraf og terapeutiske anvendelser af samme | |
EA200702584A1 (ru) | Спиробензимидазолы как ингибиторы секреции соляной кислоты | |
ATE461189T1 (de) | Neue 6-pyridylphenanthridine | |
EA200701815A1 (ru) | 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1831209 Country of ref document: EP |